FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081737093> ?p ?o ?g. }

• W2081737093 endingPage "44" @default.
• W2081737093 startingPage "34" @default.
• W2081737093 abstract "To review the safety and efficacy of thymoglobulin in pancreas transplant patients receiving tacrolimus and mycophenolate mofetil.Retrospective, single centre analysis of 45 patients transplanted between 1995 and 2000 who received 54 courses of thymoglobulin, including 36 courses in 29 solitary pancreas transplant recipients (16 pancreas alone, 13 pancreas after kidney transplants) and 18 courses in 16 simultaneous kidney-pancreas transplant patients. Thirty-two patients (71%) were primary pancreas transplants, 10 (22%) were second transplants and three (7%) were third transplants. Of the 54 treatment courses, 19 (35%) were for induction, 27 (50%) were for primary rejection and eight (15%) were rescue therapy for rejection. All rejection episodes were biopsy-proven in at least one organ.The median thymoglobulin dose was 1.5 mg/kg/d with a mean of six doses (range 3-10). Dose reduction or interruption was required in 28 courses (52%), most often due to leukopenia (n = 24), fever (n = 2) and thrombocytopenia (n = 2). Thymoglobulin was resumed in all but three patients, two with persistent fever and one with infection. Infectious complications (n = 25) occurred in 17 patients (38%) within 30 days and included bacterial (n = 16), cytomegalovirus (n = 4), polyoma (n = 1), fungal (Candida albicans, n = 1), toxoplasmosis (n = 1) and ehrlichiosis (n = 2). Post-transplant lymphoproliferative disease occurred in two patients (4%) at a mean of 70 d post-thymoglobulin treatment. In the 19 patients that received thymoglobulin induction, one simultaneous kidney-pancreas transplant, two pancreas alone and four pancreas after kidney transplant recipients developed rejection (37% incidence), while all remaining patients followed by surveillance protocol biopsies were rejection-free. In the 35 patients that received thymoglobulin for rejection, reversal occurred in 26 of the patients (74%). Rejection recurred within 30 d in five patients and post-treatment biopsies revealed persistent rejection in three of 20 pancreas and two of eight renal biopsies. After a mean follow-up of 6 months, the actual patient and pancreas graft survival rates were 93% and 71%, respectively.Thymoglobulin was effective as induction therapy in high-risk pancreas transplant recipients, and resulted in initial reversal of rejection in 74% of patients. Dose adjustments were required in over half the cases and were usually due to leukopenia. Infections occurring subsequent to thymoglobulin were not uncommon and reflected the immunosuppressive burden of the patient population." @default.
• W2081737093 created "2016-06-24" @default.
• W2081737093 creator A5001506348 @default.
• W2081737093 creator A5006876478 @default.
• W2081737093 creator A5026310911 @default.
• W2081737093 creator A5031997195 @default.
• W2081737093 creator A5037670410 @default.
• W2081737093 creator A5046333051 @default.
• W2081737093 creator A5049418764 @default.
• W2081737093 creator A5061282040 @default.
• W2081737093 creator A5064101916 @default.
• W2081737093 creator A5072424042 @default.
• W2081737093 creator A5082625908 @default.
• W2081737093 date "2002-10-01" @default.
• W2081737093 modified "2023-10-17" @default.
• W2081737093 title "Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience" @default.
• W2081737093 cites W1740384507 @default.
• W2081737093 cites W1968845033 @default.
• W2081737093 cites W1990790115 @default.
• W2081737093 cites W1991483161 @default.
• W2081737093 cites W2024130867 @default.
• W2081737093 cites W2024296188 @default.
• W2081737093 cites W2057576775 @default.
• W2081737093 cites W2079412290 @default.
• W2081737093 cites W2081177144 @default.
• W2081737093 cites W2121454052 @default.
• W2081737093 cites W2127596128 @default.
• W2081737093 cites W2169478454 @default.
• W2081737093 cites W2313824332 @default.
• W2081737093 cites W2328352945 @default.
• W2081737093 cites W2331183165 @default.
• W2081737093 doi "https://doi.org/10.1034/j.1399-0012.16.s7.5.x" @default.
• W2081737093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12372042" @default.
• W2081737093 hasPublicationYear "2002" @default.
• W2081737093 type Work @default.
• W2081737093 sameAs 2081737093 @default.
• W2081737093 citedByCount "6" @default.
• W2081737093 countsByYear W20817370932014 @default.
• W2081737093 countsByYear W20817370932021 @default.
• W2081737093 crossrefType "journal-article" @default.
• W2081737093 hasAuthorship W2081737093A5001506348 @default.
• W2081737093 hasAuthorship W2081737093A5006876478 @default.
• W2081737093 hasAuthorship W2081737093A5026310911 @default.
• W2081737093 hasAuthorship W2081737093A5031997195 @default.
• W2081737093 hasAuthorship W2081737093A5037670410 @default.
• W2081737093 hasAuthorship W2081737093A5046333051 @default.
• W2081737093 hasAuthorship W2081737093A5049418764 @default.
• W2081737093 hasAuthorship W2081737093A5061282040 @default.
• W2081737093 hasAuthorship W2081737093A5064101916 @default.
• W2081737093 hasAuthorship W2081737093A5072424042 @default.
• W2081737093 hasAuthorship W2081737093A5082625908 @default.
• W2081737093 hasConcept C126322002 @default.
• W2081737093 hasConcept C126894567 @default.
• W2081737093 hasConcept C141071460 @default.
• W2081737093 hasConcept C2777630719 @default.
• W2081737093 hasConcept C2778064082 @default.
• W2081737093 hasConcept C2778764654 @default.
• W2081737093 hasConcept C2780303639 @default.
• W2081737093 hasConcept C2911091166 @default.
• W2081737093 hasConcept C71924100 @default.
• W2081737093 hasConcept C90924648 @default.
• W2081737093 hasConceptScore W2081737093C126322002 @default.
• W2081737093 hasConceptScore W2081737093C126894567 @default.
• W2081737093 hasConceptScore W2081737093C141071460 @default.
• W2081737093 hasConceptScore W2081737093C2777630719 @default.
• W2081737093 hasConceptScore W2081737093C2778064082 @default.
• W2081737093 hasConceptScore W2081737093C2778764654 @default.
• W2081737093 hasConceptScore W2081737093C2780303639 @default.
• W2081737093 hasConceptScore W2081737093C2911091166 @default.
• W2081737093 hasConceptScore W2081737093C71924100 @default.
• W2081737093 hasConceptScore W2081737093C90924648 @default.
• W2081737093 hasLocation W20817370931 @default.
• W2081737093 hasLocation W20817370932 @default.
• W2081737093 hasOpenAccess W2081737093 @default.
• W2081737093 hasPrimaryLocation W20817370931 @default.
• W2081737093 hasRelatedWork W1533874927 @default.
• W2081737093 hasRelatedWork W1893922067 @default.
• W2081737093 hasRelatedWork W2030458438 @default.
• W2081737093 hasRelatedWork W2113671093 @default.
• W2081737093 hasRelatedWork W2168029228 @default.
• W2081737093 hasRelatedWork W2286655647 @default.
• W2081737093 hasRelatedWork W2312778006 @default.
• W2081737093 hasRelatedWork W2469546285 @default.
• W2081737093 hasRelatedWork W2806346242 @default.
• W2081737093 hasRelatedWork W3046381002 @default.
• W2081737093 hasVolume "16" @default.
• W2081737093 isParatext "false" @default.
• W2081737093 isRetracted "false" @default.
• W2081737093 magId "2081737093" @default.
• W2081737093 workType "article" @default.